InvestorsHub Logo
Followers 0
Posts 484
Boards Moderated 0
Alias Born 10/10/2014

Re: None

Wednesday, 01/11/2017 11:49:28 AM

Wednesday, January 11, 2017 11:49:28 AM

Post# of 2099
Regarding VB-111 and checkpoint inhibitor, any knowledge/guess as to which one? I'm thinking nivolumab ... but that's just wishful thinking.

=========
In addition, we intend to launch a Phase 3 pivotal study in platinum-resistant Ovarian Cancer during the second half of 2017 and are also exploring the launch of an exploratory clinical study of VB-111 in combination with a checkpoint inhibitor.
=========
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News